Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heck Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101161621A details a novel Heck reaction for trifluoromethyl acetophenone using solid base resin, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113845478A details a scalable total synthesis of oxycodone using asymmetric hydrogenation and Heck coupling, offering a reliable alternative to poppy extraction for pharmaceutical intermediates.
Patent CN101084197A reveals a novel palladium-catalyzed Heck coupling for rosuvastatin intermediates, offering scalable manufacturing and cost reduction strategies.
Patent CN101456852B reveals a novel two-step Heck coupling and reduction method for osthole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel sulfonate intermediate route solves scale-up yield loss and purity issues for Pemetrexed production, offering reliable supply chain solutions for global API manufacturers seeking cost-effective intermediates.
Patent CN112209951B details a novel BDTT-bi-Cd dye sensitizer achieving 8.40% efficiency. Discover scalable synthesis routes for optoelectronic materials.
Patent CN111943965A reveals a high-efficiency BDTT-im-Cd dye sensitizer with 9.13% PCE. Discover scalable synthesis and thermal stability advantages for DSSC manufacturing.
Explore the patented CN106905134B synthesis route for SMND-309. High-yield Heck reaction and Perkin condensation ensure cost reduction and supply reliability.
Novel asymmetric hydrogenation route for sitagliptin intermediate CN106146340B. High ee value >99%, cost-effective manufacturing, reliable supply chain solution.
Novel one-pot method for rilpivirine intermediate enhances purity and yield. Reliable pharmaceutical intermediates supplier offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108440759B details a novel Heck coupling route for fluorescent POSS monomers, offering enhanced thermal stability and cost reduction in electronic chemical manufacturing.
Patent CN108440759B details a novel Heck coupling route for carbazolyl POSS monomers, offering superior thermal stability and fluorescence for optoelectronic supply chains.
Patent CN102212027B reveals a robust Heck cyclization method for Sumatriptan, offering superior stability and yield over traditional acid-catalyzed processes for reliable supply.
Novel total synthesis of Buprenorphine via Heck reaction. Reduces cost and supply risk compared to poppy extraction. High ee value.
Patent CN114502560B details a novel total synthesis route for morphine derivatives. Achieve high yields and supply chain stability with our advanced pharmaceutical intermediates.
Patent CN115477630B details efficient Heck reaction synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing globally.
Novel intramolecular Heck reaction synthesis offers superior anti-fibrosis activity. Streamlined process ensures cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Patent CN102887872A details an eco-friendly synthesis of Amorolfine HCl using NMP solvent and sodium triacetoxyborohydride, offering high purity and yield for pharmaceutical supply chains.
Patent CN118561733A reveals DBDMH promoted Heck reaction for high purity intermediates. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101778809B reveals a Pd-catalyzed method for selective exo-norbornene synthesis, offering superior purity for optical films and cost reduction in electronic chemical manufacturing.